Literature DB >> 30260705

Bile acids induce visceral hypersensitivity via mucosal mast cell-to-nociceptor signaling that involves the farnesoid X receptor/nerve growth factor/transient receptor potential vanilloid 1 axis.

Wen-Ting Li1, Qing-Qing Luo1, Bo Wang1, Xin Chen1, Xiu-Juan Yan1, Hong-Yi Qiu1, Sheng-Liang Chen1.   

Abstract

Increased colonic bile acid (BA) exposure, frequent in diarrhea-predominant irritable bowel syndrome (IBS-D), can affect gut function. Nerve growth factor (NGF) is implicated in the development of visceral hypersensitivity (VH). In this study, we tested the hypothesis that BAs cause VH via mucosal mast cell (MMC)-to-nociceptor signaling, which involves the farnesoid X receptor (FXR)/NGF/transient receptor potential vanilloid (TRPV)1 axis. BAs were intracolonically administered to rats for 15 d. Visceral sensitivity to colorectal distention and colonic NGF expression were examined. BAs caused VH, an effect that involved MMC-derived NGF and was accompanied by enhanced TRPV1 expression in the dorsal root ganglia. Anti-NGF treatment and TRPV1 antagonism inhibited BA-induced VH. BAs induced NGF mRNA and protein expression and release in cultured mast cells. Colonic supernatants from patients with IBS-D with elevated colonic BA content transcriptionally induced NGF expression. In FXR-/- mice, visceral sensitivity and colonic NGF expression were unaltered after BA treatment. Pharmacological antagonism and FXR silencing suppressed BA-induced NGF expression and release in mast cells. Mitogen-activated protein kinase kinase (MKK) 3/6/p38 MAPK/NF-κB signaling was mechanistically responsible for FXR-mediated NGF expression and secretion. The findings show an MMC-dependent and FXR-mediated pronociceptive effect of BAs and identify the BA/FXR/NGF/TRPV1 axis as a key player in MMC-to-neuron communication during pain processing in IBS.-Li, W.-T., Luo, Q.-Q., Wang, B., Chen, X., Yan, X.-J., Qiu, H.-Y., Chen, S.-L. Bile acids induce visceral hypersensitivity via mucosal mast cell-to-nociceptor signaling that involves the farnesoid X receptor/nerve growth factor/transient receptor potential vanilloid 1 axis.

Entities:  

Keywords:  IBS; NF-κB; p38 MAPK; pain processing

Mesh:

Substances:

Year:  2018        PMID: 30260705     DOI: 10.1096/fj.201800935RR

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  16 in total

Review 1.  Farnesoid X receptor: a potential therapeutic target in multiple organs.

Authors:  Chao Zhang; Zixuan Wang; Qingqing Feng; Wei-Dong Chen; Yan-Dong Wang
Journal:  Histol Histopathol       Date:  2021-01-04       Impact factor: 2.303

Review 2.  Gut feelings: the microbiota-gut-brain axis on steroids.

Authors:  Sik Yu So; Tor C Savidge
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-11-03       Impact factor: 4.052

Review 3.  Metabolomics: The Key to Unraveling the Role of the Microbiome in Visceral Pain Neurotransmission.

Authors:  Adam Shute; Dominique G Bihan; Ian A Lewis; Yasmin Nasser
Journal:  Front Neurosci       Date:  2022-06-23       Impact factor: 5.152

4.  The Role of Bacteria and Its Derived Metabolites in Chronic Pain and Depression: Recent Findings and Research Progress.

Authors:  Shan Li; Dongyu Hua; Qiaoyan Wang; Ling Yang; Xinlei Wang; Ailin Luo; Chun Yang
Journal:  Int J Neuropsychopharmacol       Date:  2020-03-10       Impact factor: 5.176

5.  Altered metabolism of bile acids correlates with clinical parameters and the gut microbiota in patients with diarrhea-predominant irritable bowel syndrome.

Authors:  Wei Wei; Hui-Fen Wang; Yu Zhang; Yan-Li Zhang; Bing-Yu Niu; Shu-Kun Yao
Journal:  World J Gastroenterol       Date:  2020-12-07       Impact factor: 5.742

Review 6.  Mechanisms of microbial-neuronal interactions in pain and nociception.

Authors:  Valentina N Lagomarsino; Aleksandar D Kostic; Isaac M Chiu
Journal:  Neurobiol Pain       Date:  2020-12-11

7.  Involvement of Mast Cells in the Pathophysiology of Pain.

Authors:  Lijia Mai; Qing Liu; Fang Huang; Hongwen He; Wenguo Fan
Journal:  Front Cell Neurosci       Date:  2021-06-10       Impact factor: 5.505

8.  Mast Cells Regulate Ductular Reaction and Intestinal Inflammation in Cholestasis Through Farnesoid X Receptor Signaling.

Authors:  Vik Meadows; Lindsey Kennedy; Burcin Ekser; Konstantina Kyritsi; Debjyoti Kundu; Tianhao Zhou; Lixian Chen; Linh Pham; Nan Wu; Jennifer Demieville; Laura Hargrove; Shannon Glaser; Gianfranco Alpini; Heather Francis
Journal:  Hepatology       Date:  2021-09-09       Impact factor: 17.298

Review 9.  The Role of Transient Receptor Potential Vanilloid 1 in Common Diseases of the Digestive Tract and the Cardiovascular and Respiratory System.

Authors:  Qian Du; Qiushi Liao; Changmei Chen; Xiaoxu Yang; Rui Xie; Jingyu Xu
Journal:  Front Physiol       Date:  2019-08-21       Impact factor: 4.566

Review 10.  Bile Acid Receptor Therapeutics Effects on Chronic Liver Diseases.

Authors:  Vik Meadows; Lindsey Kennedy; Debjyoti Kundu; Gianfranco Alpini; Heather Francis
Journal:  Front Med (Lausanne)       Date:  2020-01-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.